Hereditary Angioedema: A Review. WMJ 2022 Apr;121(1):48-53
Date
04/21/2022Pubmed ID
35442579Scopus ID
2-s2.0-85128793938 (requires institutional sign-in at Scopus site) 5 CitationsAbstract
Hereditary angioedema (HAE) is a rare and disabling disorder wherein there is excessive bradykinin production, with subsequent increased vascular permeability in the superficial tissues and gastrointestinal and respiratory mucosa. This article serves as a review of the pathogenesis of the disease, as well as an update of the evidence-based new treatment recommendations to help clinicians with the diagnosis and management of HAE.
Author List
Zafra HAuthor
Heidi T. Zafra MD Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Angioedemas, HereditaryBlindness
Bradykinin
Complement C1 Inhibitor Protein
Humans